Towards host-directed therapies for tuberculosis
The treatment of tuberculosis is based on combinations of drugs that directly target Mycobacterium tuberculosis . A new global initiative is now focusing on a complementary approach of developing adjunct host-directed therapies. The treatment of tuberculosis is based on combinations of drugs that di...
Gespeichert in:
Veröffentlicht in: | Nature reviews. Drug discovery 2015-08, Vol.14 (8), p.511-512 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The treatment of tuberculosis is based on combinations of drugs that directly target
Mycobacterium tuberculosis
. A new global initiative is now focusing on a complementary approach of developing adjunct host-directed therapies.
The treatment of tuberculosis is based on combinations of drugs that directly target
Mycobacterium tuberculosis
. A new global initiative is now focusing on a complementary approach of developing adjunct host-directed therapies. |
---|---|
ISSN: | 1474-1776 1474-1784 |
DOI: | 10.1038/nrd4696 |